Clinical leishmaniasis in dogs living in the UK

P. Silvestrini, D. Batchelor, K. Allenspach, C. Maunder, M. Seth, A. Mas, T. Hill, G. Serrano, X. Roura, M. Planellas, A. J. German, J. Pastor

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


OBJECTIVES: To investigate the prevalence of leishmaniasis in dogs in the UK and to describe clinical presentation, clinicopathological abnormalities, therapeutic protocols and outcome in this non-endemic country. MATERIALS AND METHODS: Medical records of dogs diagnosed with leishmaniasis at seven referral centres in the UK were retrospectively reviewed. RESULTS: The prevalence was between 0·007 and 0·04% with a higher number of cases in southern England. All dogs had a history of travel to or from an endemic country. Lethargy, dermatological disease, decreased appetite and lameness were the most common reasons for presentation. Allopurinol was used alone for treatment in the majority of cases. CLINICAL SIGNIFICANCE: Although rare, leishmaniasis should be considered in dogs in the UK if they have compatible clinical signs and history of travel to or from endemic areas.

Original languageEnglish (US)
Pages (from-to)453-458
Number of pages6
JournalJournal of Small Animal Practice
Issue number9
StatePublished - 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2016 British Small Animal Veterinary Association


Dive into the research topics of 'Clinical leishmaniasis in dogs living in the UK'. Together they form a unique fingerprint.

Cite this